On April 14th, Abdelrahman Elsayed successfully presented the final defense of his dissertation entitled “Pharmacogenomics and Transcriptomic Approaches for Guiding Treatment Options in Pediatric Acute Myeloid Leukemia (AML)”.
On April 14th, Abdelrahman Elsayed successfully presented the final defense of his dissertation entitled “Pharmacogenomics and Transcriptomic Approaches for Guiding Treatment Options in Pediatric Acute Myeloid Leukemia (AML)”.